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Abstract
Background: Aim of this work was to describe a rare inheritance pattern of Primary Failure of Eruption (PFE) in a
small family with incomplete penetrance of PFE and a novel nonsense PTH1R variant.
Case presentation: The proband, a 26 year-old man with a significant bilateral open-bite, was diagnosed with PFE
using clinical and radiographic characteristics. DNA was extracted from the proband and his immediate family using
buccal swabs and the entire PTH1R coding sequence was analyzed, revealing a novel heterozygous nonsense
variant in exon 7 of PTH1R (c.505G > T). This variant introduces a premature stop codon in position 169, predicted
to result in the production of a truncated and non-functional protein. This variant has never been reported in association
with PFE and is not present in the Genome Aggregation Database (gnomAD). Interestingly, the c.505G > T variant has
also been identified in the unaffected mother of our proband, suggesting incomplete penetrance of PFE.
Conclusions: In this study, we report a new PTH1R variant that segregates in an autosomal dominant pattern and causes
PFE with incomplete penetrance. This underlines the diagnostic value of a thorough clinical and genetic analysis of all
family members in order to estimate accurate recurrence risks, identify subtle clinical manifestations and provide proper
management of PFE patients.
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Background
Primary Failure of tooth Eruption (PFE - OMIM #125350)
is a nonsyndromic condition that is likely the result of
multiple genetic and environmental factors that control
tooth eruption [1]. PFE is characterized by incomplete
eruption of teeth despite the absence of mechanical ob-
struction and the appearance of a normal physiological
bone resorption along the eruption path [2–4]. It is vari-
able in terms of the number and type of teeth involved
(primary or permanent) and the degree of symmetry but
only affects posterior teeth. PFE is defined by an apparent
cessation of eruption after the tooth has emerged to a
supracrestal position [5]. Typically, all teeth distal to the
most mesial affected teeth are affected [6]. The most
challenging aspect of eruption disorders is determining
the specific cause and therefore applying the appropriate
intervention. The similar clinical presentation of other
eruption disorders such as those caused by a mechanical
obstruction or mechanical failure (MFE), isolated anky-
losis characterized by infraocclusion, immobility or severe
delay of eruption, must be excluded [7, 8].
Several PFE cases have been associated with haploin-
sufficiency of the PTH1R gene (i.e. presence of only one
functional copy of the gene), located on chromosome
3p21.31 (OMIM *168468). The presence of a loss-of-
function variant in PTH1R confirms the clinical diagno-
sis and is associated with an autosomal dominant pat-
tern of inheritance. Affected individuals are therefore
heterozygous possessing one normal copy (allele) and
one non-functional allele of PTH1R [9, 10].
More than 50 different PTH1R variants have been re-
ported in PFE patients, distributed through its entire
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coding sequence and causing protein loss-of-function
[8]. Affected individuals carry one normal copy (allele)
of the PTH1R gene and a variant allele with a missense
substitution, a nonsense (stop codon) change resulting
in a truncated protein or a frameshift variant resulting in
a protein with an abnormal C-terminal domain [9, 10].
Half of the receptor activity is apparently enough to
compensate for PTH1R function in most tissues; how-
ever, haploinsufficiency may not be always enough to
allow normal tooth eruption, determining PFE with in-
complete penetrance i.e. PFE may not be present in indi-
viduals who carry a loss-of-function PTH1R variant [11].
In other cases a PFE patient has no family history since
he/she inherited a de novo mutation from the germ cell
of either parent. It is therefore important to determine if
an unaffected parent of a PFE patient is a non-penetrant
carrier of a PTH1R variant since he/she could have more
than one affected child. In any case, establishing a gen-
etic diagnosis is extremely important before planning
any orthodontic treatment, considering the high failure
rate of orthodontically assisted eruption in individuals
with PFE [5, 12].
In this report we present a patient with severe PFE
who was found to carry a novel PTH1R variant
(c.505G > T; p.Glu169Ter) that has been transmitted by
the unaffected mother, providing a typical example of in-
complete penetrance. We therefore posit that even in
isolated cases of PFE, the genetic analysis offers a valu-
able metric to predict the potential success of orthodon-
tic intervention.
Case presentation
Clinical analysis
A 26-year-old man was referred to the Orthodontic
Clinic of the “A.Gemelli” University hospital in Rome. A
clinical examination revealed the presence of a bilateral
posterior open bite (Fig. 1a-d). The panoramic radio-
graph (Fig. 1a) showed affection mainly of the lower arch
of the Type I PFE variety [4]. Given the similarity to
other PFE cases reported in the literature, genetic coun-
seling was offered to the patient and clinical examination
(including panoramic X-rays and photos) of all available
relatives - mother (II:2) (Fig. 2a-b-c-d), father (II:3), ma-
ternal aunt (II:1) and maternal grandfather (I:1), indi-
cated in Fig. 3 - was conducted at the Dental Clinic of
the Fondazione Policlinico “A.Gemelli” IRCCS in Rome,
while genetic analysis was carried out at the laboratories
of the Institute of Genomic Medicine and the Dental In-
stitute of the Catholic University (UCSC). We also mea-
sured the height of the proband and his parents,
although there was no evidence of craniofacial and skel-
etal malformations, in order to test the presence of short
stature.
This study was approved by the local Ethics Commit-
tee (#UCSC prot. 36,110/10 ID: 565), the procedures
followed were in accordance to the Declaration of
Helsinki of 1975 and subsequent revisions, and all pa-
tients involved provided a written informed consent to
participate. Patient’s information were de-identified.
DNA extraction and sequencing
Cells from saliva and oral mucosa were collected from
each available family member by buccal swabs for gen-
etic analysis of the PTH1R gene. DNA extraction and
purification was carried out using an automatic Mag-
Core Nucleic Acid Extractor. DNA concentration and
quality were measured by absorbance at 260 nm and by
the ratios of A260 nm/A280 nm. PCR primers were de-
signed using Genamics Expression DNA Sequence Ana-
lysis Software and the in Silico-PCR tool provided by the
UCSC Genome Browser (http://rohsdb.cmb.usc.edu/
GBshape/cgi-bin/hgPcr). Primer sets were designed to
include all exons and splice junctions, including a mini-
mum of 50 nucleotides of intron sequence. PCR amplifi-
cation of the 16 exons was performed using PCR Master
Mix (ProMEGA Corporation). PCR cycles consisted of
Fig. 1 Clinical records of proband: panoramic radiographic analysis (a), intraoral frontal view (b), intraoral right lateral view (c), intraoral left lateral
view (d)
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denaturation at 95 °C for 2 min, 38 cycles of 95 °C for 45
s, 55 °C for 45 s, 72 °C for 45 s, and a final elongation at
72 °C for 5 min. PCR products were purified using PCR
purification Kit EuroClone ExoStar PCR-plate, directly
sequenced on both strands using BigDyeTerminator
V3.1 and subsequently resolved on an ABI3130 or
ABI3500 Genetic Analyzer (Applied Biosystems, Foster
City, USA). Identified variations were confirmed with a
new sequencing reaction. NM_000316.2 was used as ref-
erence sequence of PTH1R gene. Identified variations
were confirmed in a new PCR and sequencing reaction.
In Silico analysis
Sequence data were inspected using Sanger Sequencing
and Fragment Analysis Software SeqScape of Applied Bio-
systems (ThermoFisher Scientific). The reference mRNA
sequence is NM_000316.3 and variants are indicated start-
ing from the first nucleotide of the coding sequence (+ 1).
The reference protein sequence is NP_000307.1 and
corresponds to a 593 aminoacid-long receptor with an
extracellular N-terminal domain (aa 1–183), 7 transmem-
brane domains (aa 184–476) and an intracellular C-
terminal domain (aa 477–593). PTH1R sequence variants
were searched in gene-specific databases, such as the Lei-
den Open Variation database - LOVD (https://databases.
lovd.nl/shared/genes/PTH1R) and the NCBI ClinVar data-
base (https://www.ncbi.nlm.nih.gov/clinvar), as well as in
general population databases, namely the NCBI Database
of Short Genetic Variation – dbSNP (https://www.ncbi.
nlm.nih.gov/snp) and the Genome Aggregation Database -
GnomAD (https://gnomad.broadinstitute.org/).
Clinical findings
The proband (III:1) is the only one in the family with a
characteristic PFE phenotype: failure of eruption of the
first molars, additional posterior teeth involvement,
supracrestal position of affected teeth (i.e. the eruption
pathway was clear) [2, 3, 11, 12]. If two or more of these
clinical and radiographic criteria are found, the probabil-
ity that PFE is caused by PTH1R variants increases [13].
Clinically, the proband (III:1) shows a severe open bite
of the lateral-posterior sectors with associated root
anomalies (extremely curved roots), especially in molars
[13]. Radiographically (Fig. 1a), it is possible to observe
the symmetrical infraocclusion of the inferior molars
and asymmetrical inclusion of the maxillary molars. In
the lower arch we observe the infraocclusion of 3.6 and
4.6 with mesio-inclination and total inclusion of both
the second and third molars of both mandibular sides.
In the upper arch, instead, the infraocclusion affected
the second right molar and both third molars (Fig. 1a-c-
d). According to the clinical classification of PFE [4], our
patient could be assigned to Type I. On the other hand,
all family members were clinically inspected and did not
show any clinical sign of PFE. Intraoral pictures and
panoramic radiograph of the mother (II:2) are shown in
Fig. 2. The proband is 173 cm tall, while his parents are
158 cm (mother II:2) and 171 cm (father II:3).
Fig. 2 Clinical records of the mother’s proband: panoramic radiographic analysis (a), intraoral frontal view (b), intraoral right lateral view (c), intraoral
left lateral view (d)
Fig. 3 Family tree with affected proband III-1 indicated in black.
Open symbols indicate unaffected individuals who do not carry the
c.505G > T variant. Individual II-2 (proband’s mother) is indicated in
gray since she carries the same variant but does not express the
phenotype. Individual I-2 (proband’s maternal grandmother) was
dead and her DNA could not be tested
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Mutational analysis
A buccal swab was obtained and DNA extracted for all
available family members (Fig. 3). Sequencing analysis
revealed a novel heterozygous nonsense variant
(c.505G > T; p.Glu169Ter) in our PFE patient (III:1),
resulting in the insertion of a premature stop codon in
exon 7 of the PTH1R gene (Fig. 4). This variant is classi-
fied as pathogenic since it results in the production of a
truncated protein, lacking all 7 transmembrane domains
and the intracellular C-terminus. The patient’s variant
was then searched in the other family members and it
was found only in the patient’s mother (II:2). The mater-
nal grandfather (I:1) did not carry the variant, but we
could not test the maternal grandmother (I:2).
Discussion and conclusions
Genetic analysis of our patient (Fig. 4) revealed a new het-
erozygous nonsense variant in exon 7 of the PTH1R gene
(c.505G > T) that introduces a premature stop codon and
likely results in the production of a truncated protein
(p.Glu169Ter) lacking all transmembrane domains and
the cytoplasmic C-terminal domain or possibly causes
mRNA degradation through nonsense-mediated decay.
This nonsense variant can be considered pathogenic also
because it was not found in public databases, both those
dedicated to specific gene variants (NCBI ClinVar and
LOVD) and those collecting variants of large heteroge-
neous groups (dbSNP and gnomAD).
However, a single nucleotide variant affecting the same
nucleotide (c.505G > A) but resulting in a missense change
(p.Glu169Lys) is reported in dbSNP (rs761172480) and
was found in 1 out of 246,264 alleles. Codon 169 is also
changed in the second position (c.506A > C), resulting in
another missense change (p.Glu169Ala), reported in
dbSNP (rs1250664469) with a frequency of 1 out of 125,
568 alleles, and in the third position (c.507G >A) resulting
in a synonymous change (rs763828859) with a frequency
of 1 out of 246,266 alleles. It would be very interesting to
know if these individuals also present with PFE, but this is
impossible since DNA samples belonging to these large
datasets have been made anonymous.
By extending the molecular analysis to other family
members, we discovered that the unaffected mother had
the same variant of the son. This finding underscores
the well-known phenomenon of reduced penetrance,
which has already been reported in a PFE family [11]
and consists in the lack of phenotypic expression of a
genetic variant that in other family members results in
the expected disorder/condition [14]. Reduced pene-
trance is an extreme form of variable expressivity and is
probably due to the combined action of other genetic,
epigenetic as well as microenvironmental factors, con-
verging on the same pathogenic pathway but different
for each individual, even in identical twins [15].
We also measured the height of proband and his par-
ents since it is known that PTH1R variants are associ-
ated to different skeletal syndromes with short stature.
Homozygous loss-of-function variants result in Blom-
strand chondrodysplasia (OMIM #215045), a perinatally
lethal recessive condition characterized by severe limb
dwarfism with short ribs, advanced skeletal maturation
and severe tooth impaction [16]. In fact, PTH1R knock-
out mice usually die at midgestation [17] but heterozy-
gous animals, which would represent the murine model
Fig. 4 Localization on exon 7 of the nonsense PTH1R variant identified in our PFE patient (a), nucleotide sequence of a normal individual (b), sequence
variant of proband III-1 (c) with the heterozygous variant G > T shown as a double peak in the electropherogram
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for PFE, were not described in detail. Two families have
been reported with non-lethal homozygous PTH1R vari-
ants resulting in Eiken syndrome (OMIM #600002)
characterized by growth retardation with abnormal bone
modeling in hands and feet, delayed skeletal maturation
and abnormal persistence of cartilage in the pelvis [18].
Interestingly, the patient with Eiken syndrome reported
by Moirangthem et al. [19] has also malposition and im-
paction of most of his teeth. On the other hand, hetero-
zygous gain-of-function variants have been identified in
patients with Jansen metaphyseal chondrodysplasia
(OMIM #156400), a dominant condition with PTH1R
hyperactivity, short stature, hypercalcemia, hypopho-
sphatemia, extreme disorganization of the metaphyses of
the long bones and tooth malposition but mostly normal
tooth eruption. PFE patients usually have normal stature,
as our proband does (173 cm tall), however we can
speculate that his mother’s short stature (158 cm) might
be a consequence of PTH1R haploinsufficiency and we
suggest that anthropometric measures of PFE family
members be systematically collected during clinical
examination.
A genetic diagnosis aimed at excluding or confirming
the presence of pathogenic variants in the PTH1R gene
should be carried out in every patient with suspected PFE
to help confirm the diagnosis and to avoid failure of
orthodontic intervention. In this report we underlined the
importance of a careful genotype-phenotype correlation
and we extended the clinical evaluation to all available
family members, including anthropometric measurements.
The nonsense variant found in our index case (c.505G >
T;p.Glu169Ter), as in previous instances, has never been
reported before and was identified in the unaffected
mother. This confirms that incomplete penetrance, as well
as variable expressivity, is a common event in PFE. Pheno-
typic variation is due to genetic, epigenetic and environ-
mental modifiers, although most physiopathological
pathways implicated in PFE remain unknown. Clinical
and genetic analysis of familial cases will assist our under-
standing of the cellular mechanisms underlying this condi-
tion and will pave the way to innovative pharmacological
treatments [20].
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